Select Page
Responsive Centered YouTube Video
Investigating the formation of abnormal amyloid fibrin clots in chronic and acute diseases
  • Researcher’s background in biochemistry and systems biology. 1:33

  • Development of omix techniques and computer techniques for data analysis. 2:01

  • Discovery of blood clotting into anomalous amyloid form. 3:01

  • Use of thioflavin T stain to identify amyloid proteins in blood clots. 3:38

  • Focus on microclots in chronic infectious diseases and long COVID. 4:19

  • Collaboration with Risha Pretorius on research related to microclots. 4:29

  • Discussion on the appearance of microclots under fluorescence. 5:05

Study on abnormal clotting mechanisms in long COVID patients raises concerns about potential embalmers' clots
  • Different examples of people with long COVID showing abnormal clotting mechanisms. 5:45

  • Implications of abnormal clotting in long COVID patients for treatment and management strategies. 5:59

  • Need for further research to determine the percentage and specific mechanisms of abnormal clotting in these patients. 7:05

  • Importance of understanding the mechanism behind the abnormal clotting in long COVID patients. 7:13

  • Presence of abnormal clots that are more resistant to being dissolved due to malfunctioning clot removal mechanism. 8:06

  • Speculation on the potential involvement of amyloid and prions in the abnormal clotting process. 8:16

  • Discussion on the formation and breakdown of fibrin molecules in clotting process. 8:31

Formation of amyloid fibrin clots may lead to serious health consequences such as embalmers' clots
  • Amyloid fibrin clots change conformation to be more resistant to fibrinolysis. 09:24

  • Microclots can aggregate and lead to disseminated intravascular coagulation. 10:02

  • Plasmin may be less effective in breaking down amyloid microclots. 11:31

  • Triple treatment for long COVID helps prevent new clots but not remove existing ones. 11:53

  • Microclots can form due to various factors like bacterial components binding to fibrinogen. 13:01

Understanding the catalysts of fibrin clots formation in relation to infection and spike proteins
  • Infection and certain estrogens can trigger fibrin clot formation. 13:25

  • Amyloid proteins catalyze the transformation into harmful forms. 14:10

  • Presence of specific molecules can initiate fibrin clot formation. 15:09

  • Demographics show differences in susceptibility to clotting mechanisms. 16:35

  • Viral spike proteins are the main catalyst for clotting, regardless of source. 17:25

  • Considerations on vaccine contents and their impact on clotting mechanisms. 17:32

Understanding the complex factors contributing to potential clotting issues post-infection or vaccination
  • Individual reactions vary due to genetic and lifestyle factors. 17:45

  • Observations of clotting issues post-infection or vaccination, with presence of Spike protein in immune cells. 18:06

  • Potential mechanisms include circulating Spike protein, bacterial interactions, and interferon response. 19:55

  • Discussion on conotoxins and toxin production by bacteria post-viral exposure. 21:11

  • Hypothesis of multi-hit mechanism involving various triggers in clotting cascade. 21:30

  • Role of interferon in managing latent viruses and potential impact on clotting issues. 21:49

Understanding the potential impact of amyloid fibrin clots on blood vessels and clot formation
  • Interferon levels fluctuate, impacting clot formation. 22:08

  • Spike protein triggers fibrinogen, leading to microclot formation. 22:46

  • Microclots can join to form continuous sheets of clot. 22:57

  • Lack of awareness about amyloid fibrin clots in the general population. 23:29

  • Clots in venous blood are observable, but their impact and destination are uncertain. 26:07

Investigating the potential of amyloid fibrin clots forming in the venous system and the importance of staining clots for analysis
  • Amyloid fibrin clots may form in the venous system due to flow-related factors and lower oxygen content. 26:46

  • Staining clots to determine if they are amyloid in nature is a simple experiment that should be conducted. 28:02